Dr. Kristen Ciomber, from Vanderbilt University, shares some of the key takeaways in colorectal cancer from the 2022 ASCO annual conference. She also speaks on having an open conversation with patients on circulating tumor DNA testing and the limitations of it as a predictive biomarker. She advices on how practitioners can be more open-minded about integrative medicine options for patients.

свернуть